Evidence map›Paper›PMID 40596818›Full record

ArticleBMC genomics2025

Circular RNA expression in ALS is progressively deregulated and tissue-dependent.

Leticia Moreno-García, Laura Moreno-Martínez, Miriam de la Torre, Sofía Macías-Redondo, Alberto García-Redondo, Rosario Osta, Janne Markus Toivonen, Ana Cristina Calvo

Abstract read
In one paragraph

Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Implications of circular transcripts in DM1 pathomechanism.Molecular therapy. Nucleic acids · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leticia Moreno-GarcíaLaboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain.
Laura Moreno-MartínezLaboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain.
Miriam de la TorreLaboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain.
Sofía Macías-RedondoAragón Health Research Institute (IIS Aragón), Biomedical Research Centre of Aragón (CIBA), Zaragoza, Spain.
Alberto García-RedondoGenetic Diagnosis and Research Lab, Neurology Department, University Hospital 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Rosario OstaLaboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain. osta@unizar.es.
Janne Markus Toivonen *Laboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain.
Ana Cristina Calvo *Laboratory of Genetics and Biochemistry (LAGENBIO), Department of Anatomy, Embryology and Animal Genetics, Veterinary Faculty, University of Zaragoza, Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Agroalimentary Institute of Aragon (IA2), Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is increasing evidence on the role of circular RNAs (circRNAs) in neuronal and muscular processes. Accordingly, their dysregulation is associated with neurodegenerative diseases and myopathies. We investigated circRNA expression in the central nervous system (CNS) and skeletal muscle, the two main tissues affected in amyotrophic lateral sclerosis (ALS).

resultsBased on circRNA sequencing analysis in spinal cord from ALS mice (SOD1G93A) followed by a literature search, 30 circRNAs potentially involved in ALS were tested. All selected circRNAs were downregulated in the SOD1G93A spinal cord, whereas only half of these were quantifiable and were generally upregulated in quadriceps muscle of SOD1G93A mice. Such tissue-dependent expression pattern was observed in both sexes and circRNA abundance in the spinal cord was higher than in the muscle, both in wild type and in SOD1G93A mice. Finally, we assessed the 18 circRNAs with the largest expression differences and the highest degree of interspecies conservation in brain samples from sporadic ALS (sALS) patients and healthy controls. Similar to the mouse model, circRNA levels tended to decrease in the CNS of sALS patients.

conclusionsExpression of circRNAs may be systematically altered in the two tissues most affected by ALS in a progressive and opposed manner. Although more detailed studies are warranted, circRNAs are potentially related to ALS etiopathogenesis and could possibly serve as future biomarkers, therapeutic targets, or customized therapeutic tools to modulate the pathology.

Indexed as

Amyotrophic Lateral SclerosisGene Expression RegulationRNA, CircularAnimalsDisease Models, AnimalFemaleHumansMaleMiceMice, TransgenicMuscle, SkeletalOrgan SpecificitySpinal CordSuperoxide Dismutase-1RNA, CircularSuperoxide Dismutase-1Amyotrophic lateral sclerosisCentral nervous systemCircular RNANeurodegenerationNon-coding RNASkeletal muscleSOD1G93A mice

Identifiers

PMID40596818
PMCPMC12211884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.